Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

SELL
$310.63 - $364.82 $13,978 - $16,416
-45 Reduced 1.52%
2,919 $1 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $202,254 - $235,667
629 Added 26.94%
2,964 $1.08 Million
Q3 2022

Oct 06, 2022

BUY
$296.48 - $337.87 $1,185 - $1,351
4 Added 0.17%
2,335 $755,000
Q2 2022

Jul 14, 2022

SELL
$278.73 - $327.27 $85,291 - $100,144
-306 Reduced 11.6%
2,331 $756,000
Q1 2022

Apr 28, 2022

BUY
$234.69 - $291.66 $163,344 - $202,995
696 Added 35.86%
2,637 $755,000
Q4 2021

Jan 27, 2022

SELL
$224.85 - $279.04 $53,289 - $66,132
-237 Reduced 10.88%
1,941 $536,000
Q3 2021

Oct 25, 2021

SELL
$221.6 - $272.71 $39,223 - $48,269
-177 Reduced 7.52%
2,178 $503,000
Q2 2021

Jul 20, 2021

SELL
$180.55 - $233.54 $33,401 - $43,204
-185 Reduced 7.28%
2,355 $540,000
Q1 2021

Apr 21, 2021

BUY
$164.32 - $212.72 $118,803 - $153,796
723 Added 39.79%
2,540 $474,000
Q4 2020

Feb 11, 2021

SELL
$130.46 - $172.63 $15,133 - $20,025
-116 Reduced 6.0%
1,817 $307,000
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $34,361 - $39,745
235 Added 13.84%
1,933 $286,000
Q2 2020

Aug 06, 2020

BUY
$136.42 - $164.18 $231,641 - $278,777
1,698 New
1,698 $278,000
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $70,741 - $79,251
-668 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $57,354 - $71,683
668 New
668 $72,000
Q2 2018

Aug 15, 2018

SELL
$75.7 - $86.88 $54,731 - $62,814
-723 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $222 - $262
-3 Reduced 0.41%
723 $56,000
Q4 2017

Feb 14, 2018

SELL
$81.94 - $87.89 $24,745 - $26,542
-302 Reduced 29.38%
726 $61,000
Q3 2017

Nov 15, 2017

BUY
$77.07 - $85.54 $9,864 - $10,949
128 Added 14.22%
1,028 $88,000
Q2 2017

Aug 15, 2017

BUY
N/A
900
900 $74,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Krilogy Financial LLC Portfolio

Follow Krilogy Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.